Research Projects & Grants

For Profit Organization

  • A Phase 2 Double-Blind, Placebo-Controlled, Adaptive, Dose-Escalation Study to Evaluate the Safety and Efficacy of AGN-151607-DP (USAN: gemibotulinumtoxinA) for the Achievement of Primary Fascia I Closure Without the Use of Component Separation Technique, in Subjects Undergoing Open Abdominal Ventral Hernia Repair, Role: Research Coordinator/Nurse, AbbVie, Inc., (05/2026 - 05/2027) Status: Approved

Internal

  • Retrospective Study of RV /LV Ratio, Echocardiographic Findings, Biomarkers, and Pulmonary Artery Pressures in Acute Pulmonary Embolism, Role: PI, LLU Dept. of Radiology, (12/2025) Status: Approved